A remotely operated crane lifted the first of 615 fuel assemblies from Fukushima's Unit 2 pool on Tuesday. The 880 tonnes of melted fuel still inside three reactor vessels are another matter entirely.
The first drug to disable all three RAS proteins — long considered impossible to target — nearly doubled survival in advanced pancreatic cancer, from 6.7 months to 13.2 months.
The galaxy GN20 had a fully-formed stellar bar when the universe was just 1.5 billion years old. Standard models say that shouldn't be possible in a galaxy still drowning in gas.
200,000 lab-grown brain cells on a silicon chip learned to play Doom. They spent most of their time walking into walls.
A three-foot rock from space disintegrated 40 miles above New England on Saturday with the force of 300 tons of TNT. No one saw it coming. Millions heard it arrive.
NASA has signed contracts for hopping drones, autonomous rovers, and precision landers as part of a $20 billion Moon base plan. The hardware is real. The timeline is the hard part.
A clinically dead man in China received a whole pig liver and two pig kidneys — the first multi-organ xenotransplant ever performed. Within 19 hours, the liver was producing bile. The immune system caught on at hour 36.
Thirty-five patients. One infusion each. Up to 62% less LDL cholesterol, sustained for as long as 18 months. The catch: it's still very early.
Lai Ka-ying couldn't handle car rides, hated the heat, and applied with a shrug. On Sunday, she launches to China's Tiangong space station.
Starship V3 reached space and splashed down intact. The booster didn't come home. With SpaceX's $75 billion IPO weeks away, mixed results are no longer just an engineering problem.
The Pacific is warming toward thresholds not seen since 2015-16. Whether it becomes a 'super' El Niño depends on winds forecasters can't yet predict — and commodity markets already stretched by war aren't ready for.
For the first time, researchers have molecular evidence that a gene therapy vector integrated into a patient's DNA and helped drive a brain tumor. The same treatment had also saved his life.
TEPCO — the company that oversaw the Fukushima meltdown — has brought the world's largest nuclear power plant back online. The superintendent running it was at Fukushima when disaster struck.
The problem is simple enough to explain at a kitchen table. An AI just cracked what mathematicians couldn't in eight decades — by borrowing ideas from a field nobody thought was relevant.
China now accounts for 53% of all top-tier chemistry research — more than every other country in the world combined. A single Chinese university outscores entire nations.
Colossal Biosciences hatched 26 chickens from 3D-printed artificial eggshells. Independent scientists say the engineering is real — but call the company's "fully artificial egg" framing a stretch.
China approved the world's first commercial brain implant in March. A Shanghai startup's AI now decodes Mandarin from brain signals faster than people can speak it. No BCI has been cleared for sale in the US.
It started with a trip to a Singapore supermarket for leafy greens. It ended with mouse eyes producing their own NADPH under ambient light — and corneal damage reversed in five days.
A woman with three autoimmune diseases walked out of her hospital room seven days after a single infusion — of a cancer therapy. CAR T is now being tested against lupus, MS, and a growing list of conditions.
Eight of the NIAID's ten top leadership slots have been cleared — not through retirement, but forced reassignment. Meanwhile, a 78-year-old former Fauci aide faces 51 years in prison for using his personal email.
lop News
Carl Sage